Literature DB >> 11557313

Oxidative stress in brain during experimental bacterial meningitis: differential effects of alpha-phenyl-tert-butyl nitrone and N-acetylcysteine treatment.

S Christen1, M Schaper, J Lykkesfeldt, C Siegenthaler, Y D Bifrare, S Banic, S L Leib, M G Täuber.   

Abstract

Antioxidant treatment has previously been shown to be neuroprotective in experimental bacterial meningitis. To obtain quantitative evidence for oxidative stress in this disease, we measured the major brain antioxidants ascorbate and reduced glutathione, and the lipid peroxidation endproduct malondialdehyde in the cortex of infant rats infected with Streptococcus pneumoniae. Cortical levels of the two antioxidants were markedly decreased 22 h after infection, when animals were severely ill. Total pyridine nucleotide levels in the cortex were unaltered, suggesting that the loss of the two antioxidants was not due to cell necrosis. Bacterial meningitis was accompanied by a moderate, significant increase in cortical malondialdehyde. While treatment with either of the antioxidants alpha-phenyl-tert-butyl nitrone or N-acetylcysteine significantly inhibited this increase, only the former attenuated the loss of endogenous antioxidants. Cerebrospinal fluid bacterial titer, nitrite and nitrate levels, and myeloperoxidase activity at 18 h after infection were unaffected by antioxidant treatment, suggesting that they acted by mechanisms other than modulation of inflammation. The results demonstrate that bacterial meningitis is accompanied by oxidative stress in the brain parenchyma. Furthermore, increased cortical lipid peroxidation does not appear to be the result of parenchymal oxidative stress, because it was prevented by NAC, which had no effect on the loss of brain antioxidants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557313     DOI: 10.1016/s0891-5849(01)00642-6

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  13 in total

1.  Antioxidant treatment prevents cognitive impairment and oxidative damage in pneumococcal meningitis survivor rats.

Authors:  Tatiana Barichello; Ana Lucia B Santos; Geovana D Savi; Jaqueline S Generoso; Paola Otaran; Cleonice M Michelon; Amanda V Steckert; Francielle Mina; Clarissa M Comim; Felipe Dal-Pizzol; João Quevedo
Journal:  Metab Brain Dis       Date:  2012-05-17       Impact factor: 3.584

2.  Restoration of Akt activity by the bisperoxovanadium compound bpV(pic) attenuates hippocampal apoptosis in experimental neonatal pneumococcal meningitis.

Authors:  Matthias D Sury; Lorianne Vorlet-Fawer; Claudia Agarinis; Shida Yousefi; Denis Grandgirard; Stephen L Leib; Stephan Christen
Journal:  Neurobiol Dis       Date:  2010-09-25       Impact factor: 5.996

Review 3.  [N-acetyl-L-cysteine as a therapeutic option in bacterial meningitis].

Authors:  M Klein; U Koedel; H W Pfister
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

4.  L-Ascorbate Protects Against Methamphetamine-Induced Neurotoxicity of Cortical Cells via Inhibiting Oxidative Stress, Autophagy, and Apoptosis.

Authors:  Ya-Ni Huang; Ling-Yu Yang; Jing-Ya Wang; Chien-Cheng Lai; Chien-Tsai Chiu; Jia-Yi Wang
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

5.  JNK is activated but does not mediate hippocampal neuronal apoptosis in experimental neonatal pneumococcal meningitis.

Authors:  Matthias D Sury; Claudia Agarinis; Hans-Rudolf Widmer; Stephen L Leib; Stephan Christen
Journal:  Neurobiol Dis       Date:  2008-07-18       Impact factor: 5.996

6.  Adjunctive N-acetyl-L-cysteine in treatment of murine pneumococcal meningitis.

Authors:  Tobias Högen; Cornelia Demel; Armin Giese; Barbara Angele; Hans-Walter Pfister; Uwe Koedel; Matthias Klein
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

7.  Dexamethasone treatment reverses cognitive impairment but increases brain oxidative stress in rats submitted to pneumococcal meningitis.

Authors:  Tatiana Barichello; Ana Lucia B Santos; Cintia Silvestre; Jaqueline S Generoso; Andreza L Cipriano; Fabricia Petronilho; Felipe Dal-Pizzol; Clarissa M Comim; João Quevedo
Journal:  Oxid Med Cell Longev       Date:  2011-11-21       Impact factor: 6.543

8.  Covalent adduct formation between the plasmalogen-derived modification product 2-chlorohexadecanal and phloretin.

Authors:  Andreas Üllen; Christoph Nusshold; Toma Glasnov; Robert Saf; David Cantillo; Gerald Eibinger; Helga Reicher; Günter Fauler; Eva Bernhart; Seth Hallstrom; Nora Kogelnik; Klaus Zangger; C Oliver Kappe; Ernst Malle; Wolfgang Sattler
Journal:  Biochem Pharmacol       Date:  2015-01-06       Impact factor: 5.858

9.  Assessment of electrophile damage in a human brain endothelial cell line utilizing a clickable alkyne analog of 2-chlorohexadecanal.

Authors:  Christoph Nusshold; Andreas Üllen; Nora Kogelnik; Eva Bernhart; Helga Reicher; Ioanna Plastira; Toma Glasnov; Klaus Zangger; Gerald Rechberger; Manfred Kollroser; Günter Fauler; Heimo Wolinski; Babette B Weksler; Ignacio A Romero; Sepp D Kohlwein; Pierre-Olivier Couraud; Ernst Malle; Wolfgang Sattler
Journal:  Free Radic Biol Med       Date:  2015-11-11       Impact factor: 7.376

10.  Myeloperoxidase-derived oxidants induce blood-brain barrier dysfunction in vitro and in vivo.

Authors:  Andreas Üllen; Evelin Singewald; Viktoria Konya; Günter Fauler; Helga Reicher; Christoph Nusshold; Astrid Hammer; Dagmar Kratky; Akos Heinemann; Peter Holzer; Ernst Malle; Wolfgang Sattler
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.